Xconomy

AUGUST 19, 2016

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Talk about sacrifice. If drug approval were an Olympic sport, rejections would also be high drama.

Technical Review 40

Technical Review Patents .Net Study 40

SoCal Delicious

OCTOBER 8, 2012

Professor Journal. Student Journal. Loading… Tech. Developments Blog. SIGNIFICANCE PASSING-MENTION. --> Tech Titans Hit the Beach As Silicon Valley moguls go on a home-buying spree in Los Angeles, theyre reshaping the real-estate landscape. MarketWatch. MarketWatch. AllThingsDigital. AllThingsDigital.

Los Angeles 44

Los Angeles Software Review Technical Review Journal 44

Xconomy

NOVEMBER 4, 2016

—Doctors testing a combination of two immunotherapy checkpoint inhibitors, nivolumab (Opdivo) and ipilimumab (Yervoy), reported in the New England Journal of Medicine that two melanoma patients in the trial died of heart problems. —Several other biotechs released ASH abstract data, and the net effect was a drop in most stocks.

Research 40

Research Report Pricing Journal 40